News

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
A drug testing lab under scrutiny for its results is still not performing a specialized test to minimize false positive ...
The Equine Analytical Chemistry Lab is now owned Eagle Diagnostics, and will now be called the Equine Integrity & Anti-doping ...
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their ...
They are disguised as a bogus Xanax pill, often broken down to powder, and laced with fentanyl, car fentanyl, and xylazine.
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...